¡Ya estamos en ! Descubre más
icono de HEAL

Global X Funds Global X HealthTech ETF

29.65 USD
-0.72
2.37%
Al cierre Actualizado 16 oct, 4:00 p.m. EDT
1 día
-2.37%
5 días
-0.44%
1 mes
2.56%
3 meses
5.37%
6 meses
14.88%
En lo que va del año
1.19%
1 año
-8.68%
5 años
-44.26%
10 años
-36.52%

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%
Neutral
Newsfile Corp
hace 4 meses
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
Vancouver, British Columbia--(Newsfile Corp. - June 18, 2026) - Restart Life Sciences Corp. (CSE: HEAL) (FSE: HN30) (OTC Pink: NMLSF) ("Restart Life" or the "Company") is pleased to announce that its wholly owned subsidiary, Holy Crap Foods Inc., is preparing to begin harnessing predictive AI to further its e-commerce consumer and wholesale sales platform. The initiative is engineered to leverage readily available predictive consumer behavior models to optimize, monetize, and scale the brand's direct-to-consumer and business-to-business reach.
Restart Life Advances AI-Driven E-Commerce Strategy to Scale Online Sales Growth for Holy Crap Foods
Neutral
Seeking Alpha
hace 5 meses
Medical Technology Stocks: Innovation Endures As Valuations Reset
Investors are questioning the staying power of medical technology (medtech) stocks, which have fallen from grace since the COVID-19 pandemic. The starting point is to distinguish between medtech and other healthcare industries.
Medical Technology Stocks: Innovation Endures As Valuations Reset
Positivo
Seeking Alpha
hace 11 meses
Investing In Health Stocks - How Policy Clarity Is Opening Doors
The healthcare sector has experienced one of its most significant de-ratings in 35 years, with valuations now at a 30% discount to the broader market. Healthcare trades at historical valuation discounts across multiple metrics.
Investing In Health Stocks - How Policy Clarity Is Opening Doors
Negativo
Benzinga
el año pasado
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
The U.S. Food and Drug Administration's recent enforcement action against drug promotion is sending ETFs with exposure to weight-loss treatment manufacturers into question.
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs
Neutral
Seeking Alpha
el año pasado
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Neutral
Zacks Investment Research
el año pasado
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC
Doximity, Omnicell, Embecta, Cencora and EDOC are included in this Analyst Blog.
The Zacks Analyst Blog Doximity, Omnicell, Embecta, Cencora and EDOC
Neutral
InvestorPlace
hace 2 años
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Telemedicine stocks could do no wrong during the pandemic. With millions on lockdown and still in need of medical care, telemedicine stocks, like Teledoc Health (NYSE:TDOC) ranfrom about $80 to a high of $288.80.
3 Telemedicine Stocks Poised for Possible Healthcare Evolution
Positivo
InvestorPlace
hace 2 años
3 Stocks That Could Benefit from the Rise of Telemedicine
With the growing demand for telemedicine, the market could be worth about $450 billion by the time 2032 rolls around. That's according to Emergen Research.
Neutral
ETF Trends
hace 2 años
VettaFi Voices On: Accessing Disruptive Innovation
Good Morning, VettaFi Voices! Disruptive innovation is a popular topic, and it encompasses everything from bitcoin and cryptocurrency to electric vehicles to artificial intelligence.
Gráficos de precios implementados con Lightweight Charts™